Physician profile
Todd Jaffe
NPI 1629049275
$2,641.86
in general payments reported to CMS, 2019-2025
21 companies · $406 in 2025
The $406 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2021: $299 · 2023: $1,035 · 2024: $671 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,112.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,750.23 | 2021-2025 | Proclaim, Octrode, Eterna |
| Axonics, INC. | $254.10 | 2023-2024 | Axonics |
| Nevro Corp. | $107.36 | 2021 | |
| Collegium Pharmaceutical, INC. | $63.29 | 2019-2024 | Xtampza |
| Averitas Pharma INC. | $46.00 | 2023 | Qutenza |
| Daiichi Sankyo INC. | $42.88 | 2019 | |
| Saluda Medical Americas, INC. | $42.46 | 2024 | Evoke |
| Indivior INC. | $39.92 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $34.92 | 2021 | |
| Baxter Healthcare | $33.09 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Tersera Therapeutics LLC | $31.62 | 2019 | |
| Medtronic, INC. | $30.32 | 2024 | Kyphon Express II Kyphopak Tray |
| Orexo US, INC. | $27.12 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $24.61 | 2019 | |
| Alkermes, INC. | $21.94 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $18.95 | 2019 | |
| Novo Nordisk INC | $18.58 | 2021 | |
| Pernix Therapeutics Holdings, INC. | $16.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.03 | 2021 | |
| Flowonix Medical Incorporated | $12.27 | 2019 | |
| Lilly USA, LLC | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.